Chemical and biomolecular strategies for STING pathway activation in cancer immunotherapy

KM Garland, TL Sheehy, JT Wilson - Chemical reviews, 2022 - ACS Publications
The stimulator of interferon genes (STING) cellular signaling pathway is a promising target
for cancer immunotherapy. Activation of the intracellular STING protein triggers the …

Adjuvant physiochemistry and advanced nanotechnology for vaccine development

H Ren, W Jia, Y Xie, M Yu, Y Chen - Chemical Society Reviews, 2023 - pubs.rsc.org
Vaccines comprising innovative adjuvants are rapidly reaching advanced translational
stages, such as the authorized nanotechnology adjuvants in mRNA vaccines against COVID …

Selective STING stimulation in dendritic cells primes antitumor T cell responses

B Jneid, A Bochnakian, C Hoffmann, F Delisle… - Science …, 2023 - science.org
T cells that recognize tumor antigens are crucial for mounting antitumor immune responses.
Induction of antitumor T cells in immunogenic tumors depends on STING, the intracellular …

A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs

Z Liu, J Zhou, W Xu, W Deng, Y Wang, M Wang… - Cell research, 2022 - nature.com
The emergence of SARS-CoV-2 variants and potentially other highly pathogenic
sarbecoviruses in the future highlights the need for pan-sarbecovirus vaccines. Here, we …

Platforms, advances, and technical challenges in virus-like particles-based vaccines

R Gupta, K Arora, SS Roy, A Joseph… - Frontiers in …, 2023 - frontiersin.org
Viral infectious diseases threaten human health and global stability. Several vaccine
platforms, such as DNA, mRNA, recombinant viral vectors, and virus-like particle-based …

Development of variant‐proof severe acute respiratory syndrome coronavirus 2, pan‐sarbecovirus, and pan‐β‐coronavirus vaccines

J Zhou, Z Liu, G Zhang, W Xu, L Xing… - Journal of Medical …, 2023 - Wiley Online Library
The newly emerged severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
variants with high transmission rates and striking immune evasion have posed a serious …

cGAMP-adjuvanted multivalent influenza mRNA vaccines induce broadly protective immunity through cutaneous vaccination in mice

W Zhu, L Wei, C Dong, Y Wang, J Kim, Y Ma… - … Therapy-Nucleic Acids, 2022 - cell.com
Increasing preclinical and clinical results have demonstrated that mRNA vaccines efficiently
prevent infectious diseases and are safe in animal models and humans. In this study, we …

[HTML][HTML] cGAS/cGAMP/STING signal propagation in the tumor microenvironment: key role for myeloid cells in antitumor immunity

VE Mekers, VM Kho, M Ansems, GJ Adema - Radiotherapy and Oncology, 2022 - Elsevier
Abstract Cyclic GMP-AMP synthase (cGAS), second messenger 2′ 3′-cyclic GMP-AMP
(cGAMP) and stimulator of interferon genes (STING) are fundamental for sensing …

Virus-like particles against infectious disease and cancer: guidance for the nano-architect

RA Hills, M Howarth - Current Opinion in Biotechnology, 2022 - Elsevier
Highlights•Studying VLPs gives important insights into how the immune system makes
decisions.•Spacing antigens using DNA indicates the optimal separation for B cell …

Progress of cGAS-STING signaling in response to SARS-CoV-2 infection

Y Wu, M Zhang, C Yuan, Z Ma, W Li, Y Zhang… - Frontiers in …, 2022 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is an epidemic respiratory disease caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that can cause infections in …